Elon Musk’s brain implant startup Neuralink valued at about $5B
Elon Musk’s brain implant startup, Neuralink, has been valued at around $5 billion based on privately executed stock trades, according to five sources with knowledge of the matter. Recent purchases by bullish investors have boosted the valuation, ahead of the company’s May 25 announcement that US regulators had approved a human trial on its brain chip. While experts have said it could take several years for Neuralink to secure commercial use clearance, following the trial’s approval, shares have been marketed privately to investors at a $7 billion valuation. This is an improvement from the $2 billion valuation the company had in its last known fundraising in 2021. However, the speculative increase in secondary trades does not yet reflect the wider market consensus of fundraising rounds or public offerings, and the company also faces federal probes into its handling of animal research.
FAQs:
What is Neuralink?
Neuralink is a brain implant startup founded by Elon Musk in 2016. It aims to make brain-machine interfaces that allow humans to control computers and other devices with their thoughts.
What is the current valuation of Neuralink?
Based on privately executed stock trades, Neuralink’s value is estimated to be around $5 billion, while shares have been marketed privately to investors at a $7 billion valuation.
What is the potential application of Neuralink’s brain chip?
Elon Musk has said that Neuralink’s chip would allow healthy and disabled people alike to pop into neighborhood facilities for speedy surgical insertions of devices to treat obesity, autism, depression, and schizophrenia. The company aims to ultimately allow people to control computers and other devices with their minds.
What challenges does Neuralink face?
Apart from securing commercial use clearance, Neuralink has come under scrutiny from US lawmakers after it was alleged that its animal research board may have violated conflict-of-interest regulations. The company is also being investigated for potential animal-welfare violations and whether it illegally transported dangerous pathogens on chips removed from monkey brains without proper containment measures.
When was Neuralink founded?
Neuralink was founded in 2016.
Startup Neuralink, founded by Elon Musk, has an estimated value of around $5 billion with its brain implant technology.
Elon Musk’s brain implant startup, Neuralink, has seen its valuation surge in recent months based on privately executed stock trades, according to sources familiar with the matter. What was valued at nearly $2 billion just two years ago is now said to be worth around $5 billion, with some recent purchases by bullish investors boosting the valuation ahead of Neuralink’s announcement that US regulators had approved a human trial on its brain chip. Such secondary trades are an imperfect gauge of the company’s value but suggest heightened investor interest in the firm. Neuralink faces challenges, including federal probes into its handling of animal research, and experts predict it could be several more years before the chip is commercialized.